Trump plans generic drug tariffs from 2028 with two-year delay testing U.S. onshoring push

President Trump proposed tariffs on generic drugs starting in 2028, with a two-year delay to test the U.S. onshoring push. The plan aims to reshore low-cost drug production but faces challenges displacing established suppliers like India. The tariff salvo underscores Trump's goal of reducing reliance on foreign pharmaceutical manufacturing. Industry experts questioned the feasibility of the timeline.